These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 471605)

  • 1. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications.
    Halliday HL; Hirata T; Brady JP
    Pediatrics; 1979 Aug; 64(2):154-9. PubMed ID: 471605
    [No Abstract]   [Full Text] [Related]  

  • 2. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.
    Mahony L; Heymann MA; Carnero V; Brett C; Clyman RI
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():491-4. PubMed ID: 6221636
    [No Abstract]   [Full Text] [Related]  

  • 3. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
    Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
    Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
    Barrington KJ; Fox M
    Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Closure of ductus arteriosus by drug therapy and indomethacin dosage].
    Kertész E; Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1980 Mar; 121(12):735-6. PubMed ID: 7383650
    [No Abstract]   [Full Text] [Related]  

  • 9. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
    Lilien LD; Srinivasan G; Yeh TF; Pildes RS
    Pediatr Pharmacol (New York); 1985; 5(1):73-7. PubMed ID: 3887313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Closure of the ductus arteriosus by medication in low birth weight infants].
    Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1979 Oct; 120(43):2613-4. PubMed ID: 545236
    [No Abstract]   [Full Text] [Related]  

  • 13. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus.
    Achanti B; Yeh TF; Pildes RS
    Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of patient ductus arteriosus in very low birthweight infants.
    Yu VY; Knight DB; Obeyesekere HI; Mitvalsky J
    J Singapore Paediatr Soc; 1983; 25(3-4):159-66. PubMed ID: 6678365
    [No Abstract]   [Full Text] [Related]  

  • 15. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
    Yeh TF; Wilks A; Luken J; Pildes RS
    Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patency of ductus arteriosus in the premature newborn infant: diagnosis, complications, treatment].
    Agnetti A; Viola P; Zavota L; De Luca F; Squarcia U
    Pediatr Med Chir; 1984; 6(5):609-15. PubMed ID: 6535121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin therapy in premature infants of advanced postnatal age.
    Achanti B; Pyati S; Yeh TF
    J Perinatol; 1987; 7(3):235-7. PubMed ID: 3504463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin and recurrent ileal perforations in a preterm infant.
    Giacoia GP; Azubuike K; Taylor JR
    J Perinatol; 1993; 13(4):297-9. PubMed ID: 8410386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.